We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
-0.09%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$235M
AUM Growth
+$87.8M
(+60%)
Cap. Flow
+$81.1M
Cap. Flow
% of AUM
34.53%
Top 10 Holdings %
Top 10 Hldgs %
9.76%
Holding
779
New
236
Increased
178
Reduced
104
Closed
257
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.52M |
| 2 |
Keurig Dr Pepper
KDP
|
+$2.4M |
| 3 |
Wells Fargo
WFC
|
+$2.19M |
| 4 |
AET
Aetna Inc
AET
|
+$2.17M |
| 5 |
PNC Financial Services
PNC
|
+$2.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halliburton
HAL
|
+$1.39M |
| 2 |
Eaton
ETN
|
+$1.38M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$1.35M |
| 4 |
XEC
CIMAREX ENERGY CO
XEC
|
+$1.32M |
| 5 |
DaVita
DVA
|
+$1.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.9% |
| 2 | Consumer Discretionary | 14.51% |
| 3 | Industrials | 13.73% |
| 4 | Financials | 13.03% |
| 5 | Healthcare | 10.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Adobe
ADBE
$101B
| $2.37M | 1.01% |
25,300
+20,200
| +396% | +$1.75M |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $2.36M | 1% |
+8,800
| New | +$2.52M |
|
|
3
Keurig Dr Pepper
KDP
$42B
| $2.35M | 1% |
+26,300
| New | +$2.4M |
|
|
QIHU
4
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
| $2.35M | 1% |
31,040
+29,412
| +1,807% | +$2.13M |
|
5
Procter & Gamble
PG
$351B
| $2.34M | 1% |
28,400
+23,900
| +531% | +$1.93M |
|
|
CNL
6
DELISTED
CLECO CRP (HOLDING CO)
CNL
| $2.32M | 0.99% |
42,000
+38,800
| +1,213% | +$1.97M |
|
|
AET
7
DELISTED
Aetna Inc
AET
| $2.28M | 0.97% |
+20,284
| New | +$2.17M |
|
|
8
Wells Fargo
WFC
$263B
| $2.22M | 0.94% |
45,860
+44,800
| +4,226% | +$2.19M |
|
9
FirstEnergy
FE
$28.7B
| $2.21M | 0.94% |
61,307
+57,900
| +1,699% | +$1.95M |
|
|
10
PNC Financial Services
PNC
$100B
| $2.14M | 0.91% |
+25,253
| New | +$2.15M |
|
11
Citigroup
C
$222B
| $2.03M | 0.87% |
48,700
+41,300
| +558% | +$1.73M |
|
12
AerCap
AER
$24.1B
| $1.95M | 0.83% |
50,414
+47,400
| +1,573% | +$1.63M |
|
13
Broadcom
AVGO
$1.81T
| $1.95M | 0.83% |
+126,000
| New | +$1.7M |
|
14
GE Aerospace
GE
$377B
| $1.86M | 0.79% |
+12,192
| New | +$1.72M |
|
15
Deere & Co
DE
$171B
| $1.83M | 0.78% |
+23,828
| New | +$1.87M |
|
16
KeyCorp
KEY
$24.2B
| $1.81M | 0.77% |
+163,800
| New | +$1.83M |
|
17
Travel + Leisure Co
TNL
$4.75B
| $1.8M | 0.76% |
52,053
+44,300
| +571% | +$1.4M |
|
|
ARG
18
DELISTED
Airgas Inc
ARG
| $1.77M | 0.75% |
+12,514
| New | +$1.76M |
|
19
Medtronic
MDT
$111B
| $1.75M | 0.74% |
23,277
+20,400
| +709% | +$1.54M |
|
20
Pfizer
PFE
$143B
| $1.74M | 0.74% |
+62,023
| New | +$1.77M |
|
|
HOT
21
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $1.74M | 0.74% |
20,875
+17,600
| +537% | +$1.2M |
|
|
WR
22
DELISTED
Westar Energy Inc
WR
| $1.74M | 0.74% |
35,000
+34,800
| +17,400% | +$1.55M |
|
23
Accenture
ACN
$101B
| $1.72M | 0.73% |
+14,900
| New | +$1.53M |
|
|
CELG
24
DELISTED
Celgene Corp
CELG
| $1.71M | 0.73% |
17,100
+15,700
| +1,121% | +$1.62M |
|
25
Teva Pharmaceuticals
TEVA
$36.5B
| $1.7M | 0.72% |
31,800
+28,200
| +783% | +$1.65M |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q1 2016 Portfolio in Review
As of Q1 2016, Seven Eight Capital held 779 positions worth $235M, up 60% from $147M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Seven Eight Capital deployed $81.1M of net new capital in Q1 2016, opening 236 new positions and adding to 178 existing holdings. Its largest new stake was Allergan plc: 8,800 shares worth $2.36M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $884K trimmed.
- Seven Eight Capital's largest Q1 2016 buy was Allergan plc: 8,800 shares worth $2.36M.
- Seven Eight Capital added most to Wells Fargo in Q1 2016, an estimated $2.19M increase.
- Seven Eight Capital's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $884K.
- Seven Eight Capital fully exited Halliburton in Q1 2016, selling an estimated $1.39M.
- Seven Eight Capital's ten largest holdings make up 9.8% of its $235M portfolio in Q1 2016.
- Seven Eight Capital opened 236 new positions and closed 257 in Q1 2016.
- Seven Eight Capital's portfolio value rose 60% quarter-over-quarter to $235M.
Based on Seven Eight Capital's 13F filing for Q1 2016, filed 16 May 2016.